An amylin analog used as a challenge test for Alzheimer's disease

INTRODUCTION: Preclinical studies demonstrate the potential of amylin in the diagnosis of Alzheimer's disease (AD). We aimed to lay the foundation for repurposing the amylin analog and a diabetes drug, pramlintide, for AD in humans. METHODS: We administered a single subcutaneous injection of 60...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Haihao, Stern, Robert A., Tao, Qiushan, Bourlas, Alexandra, Essis, Maritza D., Chivukula, Meenakshi, Rosenzweig, James, Steenkamp, Devin, Xia, Weiming, Mercier, Gustavo A., Tripodis, Yorghos, Farlow, Martin, Kowall, Neil, Qiu, Wei Qiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Featured Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424531/
https://www.ncbi.nlm.nih.gov/pubmed/28503657
http://dx.doi.org/10.1016/j.trci.2016.12.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424531/
https://www.ncbi.nlm.nih.gov/pubmed/28503657
http://dx.doi.org/10.1016/j.trci.2016.12.002

Ejemplares similares